Clinical trials: Succinic Semialdehyde Dehydrogenase, open to volunteers
Succinic Semialdehyde Dehydrogenase Deficiency
Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
Succinic Semialdehyde Dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disease that interferes with the catabolism of the major inhibitory neurotransmitter gamma-amino butyric acid (GABA) and furthermore leads to…
- Trial name
- NCT03758521
- Testing
- Transcranial magnetic stimulation (TMS), Magnetic resonance imaging (MRI), Electroencephalogram (EEG)
- Where
- 4 sites in United States, Germany and 2 more
- Volunteers
- 55 people
- Sponsor
- Boston Children's Hospital